Latest News

Pierre Fabre Laboratories and Iktos announce Integrated Drug Discovery Collaboration

Pierre Fabre and Iktos announce Integrated Drug Discovery Collaboration

Read the article01.09.2026

Press releases and recognitions

01.09.2026

Pierre Fabre Laboratories and Iktos announce Integrated Drug Discovery Collaboration

01.08.2026

Iktos announces Strategic Collaboration with Servier

11.19.2025

Iktos named Top BioTech and Life Sciences Companies of 2025

Press articles

Drug discovery’s weakest link? Why synthesis is the critical bottleneck in the age of AI

While artificial intelligence (AI) now accelerates molecular design at unprecedented speed, laboratory synthesis continues to lag behind, limiting the impact of digital innovation. Emerging frameworks such as AI-driven orchestration and cluster synthesis offer a path to reshape how laboratories align design with execution.

Read the article

Innovations in Pharmaceutical Technology |12.16.2025

Innovations in Pharmaceutical Technology | 12.16.2025

Drug discovery’s weakest link? Why synthesis is the critical bottleneck in the age of AI

Drug Target Review | 10.15.2025

Drug Target Review: Chemistry-aware AI offers new routes in small molecule design

LaBiotech.eu | 05.16.2025

Nine promising small molecule drug discovery companies to look out for in 2025

Press Contact

PR Agency

For any communication need please contact PRLab
Mail : dwain@prlab.co
Tel. : +31 202 443 748